Takeda Pharmaceutical Co., Ltd. (TAK)
18.03
-0.36
(-1.96%)
USD |
NYSE |
Mar 18, 16:00
18.04
0.00 (0.00%)
After-Hours: 20:00
Takeda Pharmaceutical Market Cap : 56.94B for March 18, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Halozyme Therapeutics, Inc. | 7.512B |
| Protagonist Therapeutics, Inc. | 6.195B |
| Eli Lilly & Co. | 819.81B |
| Sanofi | 106.61B |
| Nxera Pharma Co., Ltd. | 492.29M |
Market Cap Related Metrics
| PE Ratio | 74.88 |
| PS Ratio | 1.917 |
| Price to Book Value | 1.168 |
| Price to Free Cash Flow | 13.15 |
| Price | 18.03 |
| Earnings Yield | 1.34% |
| Operating PE Ratio | 16.26 |
| Normalized PE Ratio | 51.74 |